Analysts at StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Up 5.9 %
Shares of AEZS opened at $5.72 on Monday. The firm has a market cap of $10.26 million, a price-to-earnings ratio of -0.38 and a beta of 1.55. The business’s 50 day moving average is $4.77 and its two-hundred day moving average is $6.37. Aeterna Zentaris has a 52-week low of $3.96 and a 52-week high of $12.00.
Aeterna Zentaris Company Profile
Read More
- Five stocks we like better than Aeterna Zentaris
- Stock Average Calculator
- 3 Key Stocks to Ride China’s Stimulus-Driven Growth
- How to invest in marijuana stocks in 7 stepsĀ
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- What is Forex and How Does it Work?
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.